Hikal Limited
NSE:HIKAL.NS
386.95 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Hikal Limited |
Symbool | HIKAL.NS |
Munteenheid | INR |
Prijs | 386.95 |
Beurswaarde | 47,711,321,950 |
Dividendpercentage | 0.42% |
52-weken bereik | 260.3 - 410.9 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jai Vishwanath Hiremath |
Website | https://www.hikal.com |
An error occurred while fetching data.
Over Hikal Limited
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)